美股異動 | 908 Devices(MASS.US)漲14% 四季度虧損收窄
格隆匯3月9日丨908 Devices(MASS.US)現漲14.54%,報18.6美元,總市值5億美元。908 Devices公佈,2021年第四季度營收同比增長177%,至1580萬美元,超出市場普遍預期的1511萬美元。這主要是由手持設備收入增長262%推動,主要與多年採購訂單下向美國陸軍發貨有關。而公司營業虧損為353萬美元,而去年同期為389萬美元,同比收窄;每股收益虧損從1.48美元提高到0.12美元,超出了市場普遍預期的0.18美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.